SRT announces their Next-Generation Gene Therapy for Hemoglobin Disorders
San Rocco Therapeutics (SRT) today announced two abstracts at the upcoming 2026 ASGCT Annual Meeting highlighting its gene therapy platform, MiNiRoLu (SRT8-T87Q), and a companion diagnostic for quantifying therapeutic gene expression.
These advances address key limitations of current gene therapies for hemoglobin disorders, including high cost, manufacturing complexity, and challenging drug monitoring.
View the rest of the article here
View the PDF
Contact us
Call Us
+1 (312) 441-1800
Our Locations
United States:
100 S. Ashley Drive
Suite 600-2508
Tampa, Florida
33602
Europe:
Via Marecchia, 38
Altamura (BA)
Italy
70022